2-Chloro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 66716254, compound

HRID 2271777Notes

Reaction equation

Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12](=[O:14])[CH3:13])=[C:5]2[N:15]1[CH2:20][CH2:19][CH:18]([CH2:21][N:22]([CH3:24])[CH3:23])[CH2:17][CH2:16]1.[Cl:25][C:26]1[CH:31]=[C:30](B2OC(C)(C)C(C)(C)O2)[CH:29]=[C:28]([O:41][CH3:42])[C:27]=1[OH:43]>>[Cl:25][C:26]1[CH:31]=[C:30]([C:2]2[CH:3]=[C:4]3[C:9](=[CH:10][CH:11]=2)[N:8]=[CH:7][C:6]([C:12](=[O:14])[CH3:13])=[C:5]3[N:15]2[CH2:20][CH2:19][CH:18]([CH2:21][N:22]([CH3:23])[CH3:24])[CH2:17][CH2:16]2)[CH:29]=[C:28]([O:41][CH3:42])[C:27]=1[OH:43]

Participants

Reactant 2

HCID 177502302-Chloro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol

HCID 66715563HCID 66715563, compound

Product 1

HCID 66716254HCID 66716254, compoundYield 49.4%

Procedure

Following general procedure D, 1-(6-bromo-4-{4-[(dimethylamino)methyl]piperidin-1-yl}quinolin-3-yl)ethanone (17.7 mg, 0.045 mmol) was reacted with 2-chloro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (28 mg, 0.100 mmol) to afford the desired product (10.4 mg, 49%) as an off-white solid: 1H NMR (500 MHz, CD3OD) δ 8.76 (s, 1H), 8.32 (d, J=1.3 Hz, 1H), 8.07-7.97 (m, 2H), 7.31 (d, J=2.1 Hz, 1H), 7.25 (d, J=2.1 Hz, 1H), 4.00 (s, 3H), 3.48 (d, J=12.5 Hz, 2H), 3.16 (t, J=11.5 Hz, 2H), 2.68 (s, 3H), 2.43 (d, J=6.6 Hz, 2H), 2.36 (s, 6H), 2.01-1.85 (m, 3H), 1.67-1.54 (m, 2H); ESI MS m/z 468 [C26H30ClN3O3+H]+; HPLC>99% (AUC), tR=10.12 min.

Sources & evidence

ORD record: ord-55f432491ca64789bf540ee322511c33
Source dataset: uspto-grants-2015_09
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US09120749B2

Reaction notes

Loading…